Atopy in sarcoidosis a good prognostic sign?

Paul Minnis (Bangor, United Kingdom), Paul Minnis, Peter Riddel, David O’Dwyer, Paul Byrne, Seamas C. Donnelly

Source: International Congress 2015 – Sarcoidosis: pathogenesis
Session: Sarcoidosis: pathogenesis
Session type: Poster Discussion
Number: 3318
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Paul Minnis (Bangor, United Kingdom), Paul Minnis, Peter Riddel, David O’Dwyer, Paul Byrne, Seamas C. Donnelly. Atopy in sarcoidosis a good prognostic sign?. Eur Respir J 2015; 46: Suppl. 59, 3318

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Existence of “IgG4-related pleuritis” and its clinical features
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013

Subcutaneous sarcoidosis: A clinical analysis of nine patients
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015


Clinical and radiologic profile of the pseudotumoral silicosis
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015


Assessment of practice surrounding ABPA diagnosis and screening
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013


Granulomatous lymphadenitis: Experience of a portuguese oncologic institute
Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Year: 2015


Assessing the clinical significance of conjunctival provocation test with standardized extracts of dermatophagoides pteronyssinus in pediatric respiratory allergic disease
Source: International Congress 2014 – More paediatric asthma
Year: 2014

Usefulness of periostin as a biomarker of pediatric asthma
Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers
Year: 2015


Incidence, clinical manifestations and prognosis of cardiac sarcoidosis in patients with pulmonary sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013


The allergy profile and accompanying sinonasal pathologies in patients with bronchial asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015


Atopy as a predictor of allergic respiratory diseases in an Italian general population sample
Source: International Congress 2016 – Predictors of asthma among children and adults
Year: 2016


Thrombocytosis is associated with disease severity and outcomes in stable bronchiectasis
Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Year: 2015


Clinical phenotypes in asthmatic population with severe asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015

Childhood pulmonary sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013

Sarcoidosis: Clinical course and prognostic predictors
Source: Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases
Year: 2010

Five-year clinical study of children with atopic asthma
Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors
Year: 2014

Sensitization to moulds in patients with newly diagnosed allergic asthma
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015

Refined severity assessment of asthmatic children using molecular allergy diagnostics
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013

Overlap phenotypes of asthma in adults: Obesity and atopy
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015


Case presentation: Should we always treat IgG4-related lung disease?
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014


Clinical features of dermatitis, myositis and severe ILD. Could the  AntiSSA / Ro52 antibodies be a diagnostic and prognostic tool for Antisyntatase syndrom?
Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Year: 2018